Differentiation between SSR4+ and SSR4- cells suggests that SSR4 might regulate the interactions between ESCC tumor plasma cells and TME, possibly by modulating the MIF/CD74/CXCR4 axis. This evidence concerns the gene CD74 and esophageal squamous cell carcinoma.